Pramlintide and Insulin Glulisine Interaction
Drug interaction information between Pramlintide and Insulin Glulisine.
Pramlintide and Insulin Glulisine have a documented moderate interaction in FDA labeling.
FDA drug labeling documents a moderate-severity interaction between Pramlintide and Insulin Glulisine. Major interactions are generally avoided, moderate ones may need monitoring or a dose adjustment, and minor ones are usually low-risk. This page shows the documented mechanism and guidance. Label-documented interactions are not a complete safety review, so always confirm your own medications with a pharmacist or doctor. Educational information, not medical advice.
How They Interact
Pramlintide can increase the risk of low blood sugar when taken with insulin.
What To Do
Your doctor may need to adjust your insulin dose and you should check your blood sugar more often.
FDA Label Information
7 DRUG INTERACTIONS Table 6: Clinically Significant Drug Interactions with APIDRA Drugs that May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analog (e.g., octreotide), and sulfonamide antibiotics.
Pramlintide Also Interacts With
- Insulin Aspart moderate
- Insulin Degludec moderate
- Insulin Detemir moderate
- Insulin Glargine moderate
- Insulin Human/Insulin Isophane moderate
Insulin Glulisine Also Interacts With
- Fluoxetine moderate
- Octreotide moderate
- Albuterol minor
- Clonidine minor
- Lithium minor
Frequently Asked Questions
Can I take Pramlintide and Insulin Glulisine together?
This is a moderate interaction. Your doctor may need to adjust your insulin dose and you should check your blood sugar more often.
How serious is the interaction between Pramlintide and Insulin Glulisine?
This interaction is classified as "moderate" severity by the FDA. Moderate interactions may worsen your condition or change how your medications work.
Why do Pramlintide and Insulin Glulisine interact?
Pramlintide can increase the risk of low blood sugar when taken with insulin.
Understanding the Pramlintide and Insulin Glulisine Interaction
FDA-approved prescribing information for these two drugs flags their combination as a moderate-severity interaction. Pramlintide belongs to the Amylin Analog class and Insulin Glulisine belongs to the Rapid-Acting Insulin class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: Pramlintide can increase the risk of low blood sugar when taken with insulin. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.
Context around a specific patient determines real-world impact. Pramlintide has 13 total documented interactions on file in this dataset, and Insulin Glulisine has 9. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Your doctor may need to adjust your insulin dose and you should check your blood sugar more often. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.
An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Pramlintide or Insulin Glulisine based on a web page, speak with your prescriber or pharmacist before making any change.
Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. Always consult your healthcare provider about drug interactions.
Read our methodology - how this data is sourced, computed, and verified.